These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 62181)

  • 21. Bromocriptine and plasma-aldosterone.
    Marek J; Horky K
    Lancet; 1976 Dec; 2(8000):1409. PubMed ID: 63871
    [No Abstract]   [Full Text] [Related]  

  • 22. Bromocriptine does not inhibit the aldosterone response to sodium depletion.
    Carey RM; Van Loon GR
    J Clin Endocrinol Metab; 1982 Jul; 55(1):162-5. PubMed ID: 7042738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
    Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine - an important advance.
    Drug Ther Bull; 1976 Apr; 14(9):33-4. PubMed ID: 1278002
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modifications of the incretory pituitary response of prolactin to sulpiride after treatment with bromocryptin].
    Gianrossi R; Gallamini A; Nizzo MC; Murialdo G; Peirano L
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1568-71. PubMed ID: 1037380
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of bromocriptine on milk secretion in the rabbit.
    Taylor JC; Peaker M
    J Endocrinol; 1975 Nov; 67(2):313-4. PubMed ID: 1239483
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 29. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
    Helmerich D; Altwein JE
    Urol Res; 1976 Nov; 4(3):101-5. PubMed ID: 1037036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
    Seppälä M; Hirvonen E; Unnérus HA; Ranta T; Laatikainen T
    J Clin Endocrinol Metab; 1976 Jul; 43(1):198-200. PubMed ID: 947938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine does not modify aldosterone secretion.
    Benito P; Aljama P; Jiménez JA; Pérez-Jiménez F
    Drug Intell Clin Pharm; 1984 Jan; 18(1):80-1. PubMed ID: 6692751
    [No Abstract]   [Full Text] [Related]  

  • 33. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G; Masala A; Alagna S; Devilla L
    IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of CB 154.
    Triangle; 1975; 14(3-4):153-7. PubMed ID: 1209735
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
    Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
    Felt V; Nedvídková J; Krejcík L; Hainer V
    Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
    [No Abstract]   [Full Text] [Related]  

  • 38. Premenstrual tension and functional infertility. Aetiology and treatment.
    Benedek-Jaszmann LJ; Hearn-Sturtevant MD
    Lancet; 1976 May; 1(7969):1095-8. PubMed ID: 57506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of 2-bromo ergocryptine-methane-sulphonate (CB 154) in the rat.
    Mahajan KK; Horrobin DF; Robinson CJ
    J Endocrinol; 1975 Mar; 64(3):587-8. PubMed ID: 166134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.